XML 29 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN CAPITAL DEFICIENCY (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Beginning Balance $ (3,357) $ (26,077)
Beginning Balance (in shares) 93,489,809 85,630,157
Common stock issued for cash (net of issuance costs)   25,388
Common stock issued for cash (net of issuance costs) (in shares)   5,175,000
Share-based compensation related to stock options 347 129
Share-based compensation related to restricted stock award 1,020  
Exercise of options granted to employees and non-employees 28 7
Exercise of options granted to employees and non-employees (in shares) 12,421 17,095
Net Loss for the period (4,321) (5,904)
Ending Balance (6,283) (6,457)
Ending Balance (in shares) 93,502,230 90,822,252
Common Stock [Member]
   
Beginning Balance 93 86
Beginning Balance (in shares) 93,489,809 85,630,157
Common stock issued for cash (net of issuance costs)   5
Common stock issued for cash (net of issuance costs) (in shares)   5,175,000
Share-based compensation related to stock options      
Share-based compensation related to restricted stock award     
Exercise of options granted to employees and non-employees 1   
Exercise of options granted to employees and non-employees (in shares) 12,421 17,095
Net Loss for the period      
Ending Balance 94 91
Ending Balance (in shares) 93,502,230 90,822,252
Additional Paid-in Capital [Member]
   
Beginning Balance 180,145 145,814
Common stock issued for cash (net of issuance costs)   25,383
Share-based compensation related to stock options 347 129
Share-based compensation related to restricted stock award 1,020  
Exercise of options granted to employees and non-employees 27 7
Net Loss for the period      
Ending Balance 181,539 171,333
Accumulated Deficit [Member]
   
Beginning Balance (183,595) (171,977)
Common stock issued for cash (net of issuance costs)     
Share-based compensation related to stock options      
Share-based compensation related to restricted stock award     
Exercise of options granted to employees and non-employees      
Net Loss for the period (4,321) (5,904)
Ending Balance $ (187,916) $ (177,881)